SCHEMBL20794136

SCHEMBL20794136

OCC(O)COCCCCOCC(O)COC1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.50
KDM4E B2RXH2 3/20 0.39
PRMT5 O14744 2/20 0.37
WDR77 Q9BQA1 2/20 0.37
MAPT P10636 1/20 0.36
HTT P42858 4/20 0.35
ALDH1A1 P00352 4/20 0.35
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
RGS12 O14924 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
LPAR5 Q9H1C0 1/20 0.33
NPC1 O15118 1/20 0.33
APOBEC3A P31941 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18274656 0.90 USP2 (0.69) USP2KDM4EMAPTHTTLMNA
SCHEMBL3815044 0.88 KDM4E (0.45) USP2KDM4EPRMT5WDR77MAPT
SCHEMBL9132499 0.88 KDM4E (0.45) USP2KDM4EPRMT5WDR77MAPT
Water SCHEMBL29022494 0.86 KDM4E (0.44) USP2KDM4EPRMT5WDR77MAPT
SCHEMBL8534128 0.86 KDM4E (0.43) USP2KDM4EPRMT5WDR77MAPT
SCHEMBL23564645 0.85 USP2 (0.53) USP2KDM4EPRMT5WDR77MAPT
SCHEMBL15981157 0.84 USP2 (0.56) USP2KDM4EMAPTHTTALDH1A1
SCHEMBL22631553 0.82 HTT (0.40) USP2KDM4EPRMT5WDR77MAPT
SCHEMBL13907638 0.82 KDM4E (0.49) KDM4EPRMT5WDR77MAPTHTT
SCHEMBL20881774 0.79 KDM4E (0.38) KDM4EPRMT5WDR77MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190071517-A1 RECOGNITION OF MEMBRANE TYPE MUCIN-LIKE PROTEIN AND CLINICAL APPLICATION THEREOF KANAGAWA PREFECTURAL HOSPITAL ORGANIZATION (JP) 2019-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190071517-A1 RECOGNITION OF MEMBRANE TYPE MUCIN-LIKE PROTEIN AND CLINICAL APPLICATION THEREOF MUC1, CD44, EPCAM USP2 1191/4885KDM4E 2212/4885PRMT5 837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.